Table 3 Treatment characteristics
From: Outcomes of proton therapy for non-small cell lung cancer in patients with interstitial pneumonia
Characteristics | Median | IQR |
|---|---|---|
PTV | Â | Â |
Volume (ml) | 112.0 | (56.1–246.3) |
D2% (%) | 102.7 | (101.9–103.8) |
D50% (%) | 100.1 | (98.7–100.5) |
D95% (%) | 94.7 | (85.8–97.4) |
D98% (%) | 90.2 | (79.9–94.1) |
CI | 1.34 | (0.87–1.48) |
HI | 0.13 | (0.09–0.23) |
Lung-GTV | Â | Â |
MLD (GyRBE) | 7.9 | (3.4–11.6) |
V5GyRBE (%) | 22.2 | (11.1–31.3) |
V10GyRBE (%) | 19.5 | (8.8–27.3) |
V20GyRBE (%) | 15.8 | (6.4–20.7) |
V40GyRBE (%) | 8.0 | (3.8–13.3) |